Friday, April 17, 2015

          3Ls Hayley Reynolds & Daniel Zarchy Win at Ninth Circuit

          Case presents novel issue of whether witness tampering is categorically a crime involving moral turpitude for purposes of federal immigration proceedings, writes Stephen Tollafield, Professor & Associate Director, Legal Writing & Moot Court Department.
          Sample alt tag.
          Hastings Appellate Project students Hayley Reynolds and Daniel Zarchy with Gary Watt ‘97, Director of HAP and a partner and appellate specialist with Archer Norris, and Stephen Tollafield ’02, Associate Director of the UC Hastings Legal Writing and Moot Court Department.

          On March 10, 2015, UC Hastings third-year Hastings Appellate Project students Hayley Reynolds and Daniel Zarchy appeared at the Ninth Circuit to argue their pro bono case, Soto-Rodriguez v. Holder, Case No. 14-71419. On April 14, 2015, the team received the Court's decision in their favor. 

          Reynolds delivered the winning argument before Ninth Circuit Judges William Fletcher and Morgan Christen and visiting Fourth Circuit Judge Andre M. Davis.

          The case presents the novel issue of whether witness tampering is categorically a crime involving moral turpitude for purposes of federal immigration proceedings. The client, a lawful permanent resident of the U.S., was convicted of witness tampering in Washington state after he wrote a letter to a co-defendant pleading with the co-defendant to testify truthfully at their consolidated trial. At the appellate oral argument, Reynolds noted that although the client was convicted of witness tampering in state court, his conduct did not demonstrate the kind of “evil intent” that would justify removing him from the country and his family under the federal Immigration and Nationality Act.

          Hastings Appellate Project students are supervised by Gary Watt ‘97, Director of HAP and a partner and appellate specialist with Archer Norris, and Stephen Tollafield ’02, Associate Director of the UC Hastings Legal Writing and Moot Court Department. Now in its sixth year, HAP students provide pro bono appellate representation to indigent litigants who face sophisticated and novel legal issues that impact underrepresented and low-income communities across the country.

          Watch the Arguments!



          - ST

          Go to News Archive

          Share this Story

          Share via Facebook
          Share via TwitterShare via EmailPrint Friendly Version

          Other Recent Stories/ RSS

          Monday, November 20, 2017

          Professor Carol Izumi receives 2018 William Pincus Award for Outstanding Service and Commitment to Clinical Legal Education from the Association of American Law Schools (AALS)

          “Recipients are giants in the field and Carol belongs in their midst,” says Associate Dean Ascanio Piomelli.
          Friday, November 17, 2017

          Exciting New Spring 2018 Courses Focus on the Future

          Grabbing from the headlines and emphasizing innovation, courses like Legal Tech Startups, Advanced Immigration Law, and Stalking and Law will prepare UC Hastings students for next-level legal careers.
          Tuesday, November 14, 2017

          Port pilot John Betz ’96 discusses his non-legal career and the importance of education

          A tragic “Deadliest Catch” moment piqued a lifelong interest in the law and encouraged John to pursue a law degree at UC Hastings.
          Friday, November 03, 2017

          Thinkers & Doers: October 2017

          100 Things Warriors Fans Should Know & Do Before They Die -- Alum appointed Chargé d’Affaires -- The poisonous dynamic over who’s to blame for racism -- Prof. Williams on the Harvey Weinstein Effect -- Two More UC Hastings Grads Receive Judgeships from Gov. Brown -- Jury selection in the Steinle case -- and much more
          Wednesday, November 01, 2017

          Why do drug prices remain so high?

          "Because drug companies block competition," says Professor Feldman in a new study that examines all drugs on the market between 2005 and 2015, identifying and analyzing every instance in which the company added new patents or exclusivities. 
          Go to News Archive